Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMedicolegalUnitedHealthcare alleges billing fraud in new RP lawsuitPass-through billing has come up again in a new lawsuit alleging RP funneled in-network claims through a "sham out-of-network entity."Molecular ImagingPET/MR enterography shows promise in Crohn’s diseaseAIPatient-facing AI shifts focus from reports to relationshipsMRIDTI-MRI shows childhood neglect's effect on the brain's white matterUltrasoundEcho images show consequences of steroid use among athletes